PeptiDream (TSE:4587) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4587 PeptiDream Inc TSE:4587
72 GF Score
Price 円954.40
GF Value 円1,749.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PeptiDream FFO per Share?

FFO per Share only applies to REITs.

TSE:4587
72GF Score
PeptiDream Inc TSE:4587
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PeptiDream (TSE:4587) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of 円954.40 is trading 45.4% below its estimated GF Value™ of 円1,749.45. GuruFocus considers PeptiDream to be Possible Value Trap.

Key valuation signals for TSE:4587:

  • FFO per Share:
  • GF Value™: 円1,749.45 vs. price of 円954.40 (45.4% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the TSE:4587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges PPTDF:USA
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
72GF Score

Get the complete analysis for TSE:4587

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円954.40
Price
円1,749.45
GF Value